BioNexus Gene Lab Corp Common stock (BGLC) — Free Cash Flow Generation Index
BioNexus Gene Lab Corp Common stock (BGLC) has a Free Cash Flow Generation Index of 0.96x as of December 2022. Free cash flow of $457.44K represents 1% of operating cash flow ($474.47K). Read debt load of BioNexus Gene Lab Corp Common stock for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
BioNexus Gene Lab Corp Common stock Free Cash Flow Generation Index (2017–2022)
Historical FCF Generation Index trend for BioNexus Gene Lab Corp Common stock across 4 annual periods. Explore reinvestment intensity of BioNexus Gene Lab Corp Common stock to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for BioNexus Gene Lab Corp Common stock (2017–2022)
Year-by-year Free Cash Flow Generation Index for BioNexus Gene Lab Corp Common stock. For the full company profile including market capitalisation, see BioNexus Gene Lab Corp Common stock stock valuation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.90x | $489.86K | $544.03K | $54.17K | ▲ +37.5% |
| 2021 | 0.65x | $6.00K | $9.16K | $3.16K | ▲ +176.1% |
| 2020 | 0.24x | $131.06K | $552.68K | $421.62K | ▲ +99.8% |
| 2017 | 0.12x | $42.40K | $357.22K | $314.82K | — |